Clinical Trials Directory

Trials / Unknown

UnknownNCT04379219

Surgery Alone Versus Methotrexate Before Surgery in Cesarean Scar Pregnancy

Surgery Alone Versus Methotrexate Before Surgery in Cases of First Trimester Cesarean Scar Pregnancy: a Randomized Controlled Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
56 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

There are no universal treatment guidelines available. The ultimate purpose of the management of CSP is to simultaneously remove the pregnancy and successfully preserve the woman's fertility (Gonzalez \& Tulandi, 2017). A variety of medical and surgical treatment modalities for CSP have been reported; however, most of these are based on low-level evidence(Sun et al., 2019).

Detailed description

This will be a randomized clinical trial to evaluate the effect of administration of methotrexate before surgery in reducing bleeding, injury to bladder and ureter, operative time and removing of CSP mass.This will be in comparison to surgery alone in cases of first trimester cesarean scar pregnancy

Conditions

Interventions

TypeNameDescription
DRUGMethotrexategiving methotrexate at least 1 w week before surgery

Timeline

Start date
2019-12-01
Primary completion
2020-08-01
Completion
2020-12-01
First posted
2020-05-07
Last updated
2020-05-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04379219. Inclusion in this directory is not an endorsement.

Surgery Alone Versus Methotrexate Before Surgery in Cesarean Scar Pregnancy (NCT04379219) · Clinical Trials Directory